article_metadata: Diego Curtò Federica Tomatis Sara Gastoldi Miriam Galbusera Marina Noris Federico Raimondi Ferdinando Luca Lorini Anna Falanga Marina Marchetti Giuseppe Remuzzi Piero Ruggenenti
article_metadata: 10.3389/fimmu.2021.711915
article_metadata: Front Immunol
article_metadata: 2021 Jun 30;12:711915.
article_metadata: covid-19 case report coagulation biomarkers convalescent antibodies double filtration plasmapheresis hypercoagulability immunosuppression rituximab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34276706/
article_metadata: Antibodies, Neutralizing / therapeutic use Antibodies, Viral / therapeutic use COVID-19 / therapy Immunization, Passive / methods Immunocompromised Host Immunoglobulin G / therapeutic use Plasmapheresis / methods SARS-CoV-2 / genetics
article_metadata: Antibodies, Neutralizing / therapeutic use Antibodies, Viral / therapeutic use COVID-19 / therapy Immunization, Passive / methods Immunocompromised Host Immunoglobulin G / therapeutic use Plasmapheresis / methods SARS-CoV-2 / genetics Case Reports Research Support, Non-U.S. Gov't Antineoplastic Agents, Immunological / adverse effects Antiviral Agents / therapeutic use COVID-19 / immunology COVID-19 / virology COVID-19 Serotherapy Female Humans Immunity / drug effects Lymphoma, Large B-Cell, Diffuse / drug therapy Middle Aged RNA, Viral / genetics Rituximab / adverse effects Treatment Outcome Antibodies, Neutralizing Antibodies, Viral Antineoplastic Agents, Immunological Antiviral Agents Immunoglobulin G RNA, Viral Rituximab
article_metadata: PMC8278474
article_metadata: 34276706
article_metadata: Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
article_metadata: 2021